Mario Skugor is an Endocrinology/Metabolic physician affiliated with Cleveland Clinic. OpenAlex indexes 39 publications with 1,359 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ascendis Pharma Endocrinology IncProgram year202538 payments$43,391
- Novo Nordisk IncProgram year20252 payments$69
- Novo Nordisk IncProgram year20242 payments$53
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
48.1%GLP-1 receptor agonist10.9%Ozempic51%Trulicity32%Mounjaro17%Part D<11 patientsBiguanide (metformin)9.3%Metformin Hcl65%Metformin Hcl Er35%Part D≥37 patients+ 7 more classes in this area
Hormonal (systemic)
39.8%l-Thyroxine34.7%Levothyroxine Sodium78%Synthroid22%Part D≥192 patientsThyroid Hormone Synthesis Inhibitor1.9%Methimazole100%Part D≥18 patients+ 3 more classes in this area
Cardiovascular
7.9%Statin4.3%Atorvastatin Calcium45%Rosuvastatin Calcium22%Simvastatin17%Pravastatin Sodium16%Part D<11 patientsCholesterol absorption inhibitor1.1%Ezetimibe100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Reimbursement for Thyroid Surgery and Potential Solutions
JAMA Otolaryngology–Head & Neck Surgery
2025 - Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer
JAMA Otolaryngology–Head & Neck Surgery
2023 - Decreased bone mass in adolescents with bone fragility fracture but not in young children: a case–control study
Frontiers in Endocrinology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Nissen, MD
Cleveland Clinic
Samir Kapadia, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Serpil Erzurum, MD
Cleveland Clinic
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”